C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/15/2011	US20110306135 Method for producing tooth
12/15/2011	US20110306134 Retention of a stem cell phenotype
12/15/2011	US20110306133 Culture medium and method for inducing differentiation into adipocytes
12/15/2011	US20110306132 Culture medium and method for inducing differentiation into bone cells
12/15/2011	US20110306131 Induction of pluripotent stem cells into mesodermal lineages
12/15/2011	US20110306130 Induction of pluripotent stem cells into mesodermal lineages
12/15/2011	US20110306129 Stem cell growth media and methods of making and using same
12/15/2011	US20110306128 Culture of cells
12/15/2011	US20110306127 Enhancing iron uptake in protein-free media
12/15/2011	US20110306126 Method for producing antibody directed against protein expressed on cell surface
12/15/2011	US20110306125 Protein Expression Methods
12/15/2011	US20110306124 Method for detoxifying a biological tissue
12/15/2011	US20110306123 Method for preparing biological tissues for use in biological prostheses
12/15/2011	US20110306122 Hanging Drop Plate
12/15/2011	US20110306110 Method for three-dimensional hierarchical cell co-culture
12/15/2011	US20110306098 Compositions and methods for use in isolation of nucleic acid molecules
12/15/2011	US20110306095 Methods for selecting eukaryotic cells expressing a heterologous protein
12/15/2011	US20110306092 Expression vector system comprising two selection markers
12/15/2011	US20110306090 Mammalian Expression Vector
12/15/2011	US20110306081 Microfluidic Device
12/15/2011	US20110306061 Inhibitors of myelin-associated glycoprotein (mag) activity for regulating neural growth and regeneration
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110306041 Device for cell culture
12/15/2011	US20110305784 Fractionated products obtained from gamboge resin, and medical uses of the same
12/15/2011	US20110305777 Dimeric iap antagonists
12/15/2011	US20110305774 Treatment of retroviral reservoirs exploiting oxidative stress
12/15/2011	US20110305772 Compositions and methods for ex vivo hepatic nucleic acid delivery
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305769 Branched cationic lipids for nucleic acids delivery system
12/15/2011	US20110305750 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
12/15/2011	US20110305749 HIV-1 Envelope Polypeptides for HIV Vaccine
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305718 Recombinant Protein Body-Inducing Polypeptides
12/15/2011	US20110305717 Cultured myeloid dendritic cells isolated from peyer's patches and uses thereof
12/15/2011	US20110305715 Antibodies to 3-hydroxycotinine and methods of use thereof
12/15/2011	US20110305714 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
12/15/2011	US20110305713 Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
12/15/2011	US20110305712 Ctla4 proteins and their uses
12/15/2011	US20110305706 Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305701 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305696 anti-serum albumin binding variants
12/15/2011	US20110305695 Wnt Antagonists and Methods of Treatment and Screening
12/15/2011	US20110305694 Multivalent and/or multispecific rankl-binding constructs
12/15/2011	US20110305693 Anitigen-binding constructs
12/15/2011	US20110305692 Antigen-binding contructs
12/15/2011	US20110305689 Treatment of chronic inflammatory respiratory disorders
12/15/2011	US20110305687 Anti-fgfr2 antibodies
12/15/2011	US20110305680 Composition Containing Osteopontin for Differentiating Natural Killer Cell as an Active Ingredient and a Method of Differentiation Using Thereof
12/15/2011	US20110305677 Human embryonic stem cell cultures, and compositions and methods for growing same
12/15/2011	US20110305675 Methods for expansion of hematopoietic stem and progenitor cells
12/15/2011	US20110305673 Compositions and methods for tissue repair
12/15/2011	US20110305672 COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
12/15/2011	US20110305667 Use of a dead-box rna helicase for inducing cytokine production
12/15/2011	US20110305663 Serum albumin binding molecules
12/15/2011	US20110305638 Modulation of Macrophage Activation
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	DE102010056626A1 Bypassing end replication defect comprises replacing RNA primers by RNAse H from DNA strand during cell division, which activates new DNA strand e.g. by neurotransmitters, hence new cell division arises and chromosomes do not become shorter
12/15/2011	CA2805165A1 3-dimensional scaffolds for improved differentiation of pluripotent stem cells to hepatocytes
12/15/2011	CA2802203A1 Compositions and methods of treating no-option critical limb ischemia (cli)
12/14/2011	EP2395084A1 Transgenic plants expressing CIVPS or intein modified proteins and related method
12/14/2011	EP2395083A1 Transgenic plants expressing CIVPS or intein modified proteins and related method
12/14/2011	EP2395080A1 Cellobiose 2-epimerase, process for producing same, and use of same
12/14/2011	EP2395077A1 Glycolysis-inhibiting substances in cell culture
12/14/2011	EP2395076A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/14/2011	EP2395055A1 Fluorescent solvatochromic pigment
12/14/2011	EP2395024A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395023A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395017A2 Design and use of paired variable regions of specific binding molecules
12/14/2011	EP2395016A2 Design and use of paired variable regions of specific binding molecules
12/14/2011	EP2394662A2 Methods and compositions for treating and preventing disease associated with AlphavBeta5 intergrin
12/14/2011	EP2394660A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/14/2011	EP2394659A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2393925A1 Protein and dna sequence encoding a cold adapted xylanase
12/14/2011	EP2393920A1 Treatment of limb ischemia
12/14/2011	EP2393919A1 Novel permanent human cell line
12/14/2011	EP2393918A1 Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells
12/14/2011	EP2393917A2 Culture medium for epithelial stem cells and organoids comprising said stem cells.
12/14/2011	EP2393916A2 Therapeutic use of specialized endothelial progenitor cells
12/14/2011	EP2393915A1 Method of producing progenitor cells from differentiated cells
12/14/2011	EP2393914A1 Tissue engineering of lung
12/14/2011	EP2393913A1 Cardiomyocytes-containing device and method for manufacturing and using the same
12/14/2011	EP2393824A2 Plasmodium malariae and plasmodium ovale genes and uses thereof
12/14/2011	EP2393505A1 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
12/14/2011	EP2393501A1 Method and means for producing tissues and tissues obtained
12/14/2011	EP1993574B1 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance
12/14/2011	EP1921140B1 Mutant transposon vector and use thereof
12/14/2011	EP1918374B1 Novel diglycosidase and gene encoding the same
12/14/2011	EP1877544B1 Recovery of tissue function following administration of b cells to injured tissue
12/14/2011	EP1789063B1 Tissue engineered meat for consumption and a method for producing tissue engineered meat for consumption
12/14/2011	EP1005488B2 Receptor that binds trail
12/14/2011	CN1938419B 通过细胞巨团培养产生的细胞组织样组构和宏观组织样构建体以及巨团培养方法 Produced by cells cultured cells macromass tissue-like organization and macroscopic tissue-like constructs and methods macromass culture
12/14/2011	CN1888072B 一种乳腺生物反应器的建立方法 A method of establishing the bioreactor breast
12/14/2011	CN1882690B 从新hcv株衍生的核酸和基因以及使用所述基因的复制子-复制细胞 Hcv new strains and gene-derived nucleic acids and the use of said gene replicon - replicating cells
12/14/2011	CN1871355B 从cDNA中回收非节段性负链RNA病毒的改进方法 Recovering an improved method of non-segmental negative-strand RNA viruses from cDNA in
12/14/2011	CN1756836B 干细胞和祖细胞分化的调节、鉴定及其应用 Regulating stem cell and progenitor cell differentiation, characterization and application of
12/14/2011	CN1582337B 丙型肝炎病毒疫苗 Hepatitis C virus vaccine
12/14/2011	CN1341148B 编码交替蔗糖酶的核酸分子 Encoding nucleic acid molecule alternating invertase

1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 1827